- Home
- SEER vs CEE Comparison
SEER vs CEE Comparison
Compare SEER & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.83
Company Overview
Basic Information| Metric | SEER | CEE |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.0M | 101.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SEER | CEE |
|---|---|---|
| Price | $1.83 | $16.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 156.8K | 22.0K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.86% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,376,999.00 | N/A |
| Revenue This Year | $22.37 | N/A |
| Revenue Next Year | $30.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.11 | N/A |
| 52 Week Low | $1.62 | $7.80 |
| 52 Week High | $2.59 | $10.32 |
Technical Indicators
Market Signals| Indicator | SEER | CEE |
|---|---|---|
| Relative Strength Index (RSI) | 28.36 | 65.23 |
| Support Level | $1.85 | $16.20 |
| Resistance Level | $2.02 | $16.77 |
| Average True Range (ATR) | 0.08 | 0.36 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 7.32 | 92.79 |
Price Performance
Historical Comparison SEER
CEE
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.